Survivor costs in cost-effectiveness analysis - Response

被引:0
|
作者
Golan, Y [1 ]
Wong, JB [1 ]
Pauker, SG [1 ]
机构
[1] Tufts Univ, New England Med Ctr, Boston, MA 02111 USA
关键词
D O I
10.7326/0003-4819-144-7-200604040-00021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:535 / 535
页数:1
相关论文
共 50 条
  • [41] Cost-effectiveness analysis
    Stein, Sherman C.
    Malhotra, Neil R.
    Burnett, Mark G.
    JOURNAL OF NEUROSURGERY-SPINE, 2014, 20 (04) : 474 - 474
  • [42] COST-EFFECTIVENESS ANALYSIS
    GANIATS, TG
    PRIMARY CARE, 1995, 22 (02): : 307 - 318
  • [43] Cost-effectiveness analysis
    Yates, BT
    EVALUATION AND PROGRAM PLANNING, 2002, 25 (02) : 201 - 202
  • [44] COST-EFFECTIVENESS ANALYSIS
    BALAKRISHNA, S
    JOURNAL OF RURAL DEVELOPMENT, 1992, 11 (05) : 701 - 703
  • [45] DISCOUNTING HEALTH AND COST-EFFECTIVENESS ANALYSIS: A RESPONSE TO NORD
    Hammitt, James K.
    HEALTH ECONOMICS, 2012, 21 (07) : 878 - 882
  • [46] Cost-Effectiveness Analysis in Development: Accounting for Local Costs and Noisy Impacts
    Evans, David K.
    Popova, Anna
    WORLD DEVELOPMENT, 2016, 77 : 262 - 276
  • [47] Bayesian models for cost-effectiveness analysis in the presence of structural zero costs
    Baio, Gianluca
    STATISTICS IN MEDICINE, 2014, 33 (11) : 1900 - 1913
  • [48] Incorporating future unrelated medical costs in cost-effectiveness analysis in China
    Jiang, Shan
    Wang, Yitong
    Zhou, Junwen
    Jiang, Yawen
    Liu, Gordon Guo-En
    Wu, Jing
    BMJ GLOBAL HEALTH, 2021, 6 (10):
  • [49] Productivity costs in cost-effectiveness analysis: Numerator or denominator: A further discussion
    Brouwer, WBF
    Koopmanschap, MA
    Rutten, FFH
    HEALTH ECONOMICS, 1997, 6 (05) : 511 - 514
  • [50] Costs and cost-effectiveness of rhDNase in cystic fibrosis - A systematic literature analysis
    Jalilvand, N
    Krauth, C
    Schwartz, FW
    GESUNDHEITSWESEN, 2001, 63 (8-9) : A72 - A72